Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AstraZeneca demonstrates Tagrisso’s superiority to other EGFR-TKI drugs

pharmaceutical-technologyAugust 12, 2019

Tag: AstraZeneca , Tagrisso , Drug

PharmaSources Customer Service